Waterborne and sediment toxicity of fluoxetine to select organisms

Baylor University, Waco, Texas, United States
Chemosphere (Impact Factor: 3.5). 08/2003; 52(1):135-42. DOI: 10.1016/S0045-6535(03)00103-6
Source: PubMed

ABSTRACT Ecological risk assessments of pharmaceuticals are currently difficult because little-to-no aquatic hazard and exposure information exists in the peer-reviewed literature for most therapeutics. Recently several studies have identified fluoxetine, a widely prescribed antidepressant, in municipal effluents. To evaluate the potential aquatic toxicity of fluoxetine, single species laboratory toxicity tests were performed to assess hazard to aquatic biota. Average LC(50) values for Ceriodaphnia dubia, Daphnia magna, and Pimephales promelas were 0.756 (234 microg/l), 2.65 (820 microg/l), and 2.28 microM (705 microg/l), respectively. Pseudokirchneriella subcapitata growth and C. dubia fecundity were decreased by 0.044 (14 microg/l) and 0.72 microM (223 microg/l) fluoxetine treatments, respectively. Oryias latipes survival was not affected by fluoxteine exposure up to a concentration of 28.9 microM (8.9 mg/l). An LC(50) of 15.2 mg/kg was estimated for Chironomus tentans. Hyalella azteca survival was not affected up to 43 mg/kg fluoxetine sediment exposure. Growth lowest observed effect concentrations for C. tentans and H. azteca were 1.3 and 5.6 mg/kg, respectively. Our findings indicate that lowest measured fluoxetine effect levels are an order of magnitude higher than highest reported municipal effluent concentrations.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Selective serotonin re-uptake inhibitors (SSRIs) antidepressants are amongst the most prescribed pharmaceutical active substances throughout the world. Their presence, already described in different environmental compartments such as wastewaters, surface, ground and drinking waters, and sediments, and their remarkable effects on non-target organisms justify the growing concern about these emerging environmental pollutants. A comprehensive review of the literature data with focus on their footprint in the aquatic biota, namely their uptake, bioaccumulation and both acute and chronic ecotoxicology is presented. Long-term multigenerational exposure studies, at environmental relevant concentrations and in mixtures of related compounds, such as oestrogenic endocrine disruptors, continue to be sparse and are imperative to better know their environmental impact. Copyright © 2014 Elsevier Ltd. All rights reserved.
    Environmental Pollution 12/2014; 197C:127-143. DOI:10.1016/j.envpol.2014.12.002 · 3.90 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) widely used in the treatment of major depression. It has been detected in surface and wastewaters, being able to negatively affect aquatic organisms. Most of the ecotoxicity studies focused only in pharmaceuticals, though excipients can also pose a risk to non-target organisms. In this work the ecotoxicity of five medicines (three generic formulations and two brand labels) containing the same active substance (fluoxetine hydrochloride) was tested on the alga Chlorella vulgaris, in order to evaluate if excipients can influence their ecotoxicity. Effective concentrations that cause 50% of inhibition (EC50) ranging from 0.25 to 15 mg L(-1) were obtained in the growth inhibition test performed for the different medicines. The corresponding values for fluoxetine concentration are 10 times lower. Higher EC50 values had been published for the same alga considering only the toxicity of fluoxetine. Therefore, this increase in toxicity may be attributed to the presence of excipients. Thus more studies on ecotoxicological effects of excipients are required in order to assess the environmental risk they may pose to aquatic organisms.
    Environmental Technology 12/2014; 35(24):3124-3129. DOI:10.1080/09593330.2014.932438 · 1.20 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Sertraline (''Zoloft'') is a selective serotonin reuptake inhibitor (SSRI) suspected of causing developmental abnormalities in some aquatic organisms at environmentally relevant concentrations. SSRIs have been detected downstream from wastewater treatment plants, but the risks associated with environmental exposure have not been well documented. We tested the effects of sertraline on development of Wood Frog (Lithobates sylvaticus) larvae. Tadpoles hatched from wild-collected egg masses were exposed to concentrations of 0, 0.1, 1.0, or 10.0 lg/L of sertraline through metamorphosis. We tracked tadpole development using image analysis (452 digital images) to estimate mass periodically during the tadpole stage, and we also recorded mass at metamorphosis. Time to metamorphosis did not differ between treatments, but sertraline-exposed tadpoles grew less when raised among conspecifics. However, this effect was not detected when the study was repeated with tadpoles raised individually. This indicates that the effects of sertraline and other SSRIs may be enhanced when tadpoles are raised under more stressful conditions.
    Journal of Herpetology 12/2014; 48(4):571-576. DOI:10.1670/13-058 · 0.84 Impact Factor


Available from
Jun 3, 2014